A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Surgical robotic maker Shenzhen Edge announces $154M HKEX IPO
Surgical robotic maker Shenzhen Edge announces $154M HKEX IPO
Holiday notice
Holiday notice
Med-tech IPOs 2025
Med-tech IPOs 2025
Financings for Dec. 31, 2025
Financings for Dec. 31, 2025
In the clinic for Dec. 31, 2025
In the clinic for Dec. 31, 2025
Other news to note for Dec. 31, 2025
Other news to note for Dec. 31, 2025
Regulatory actions for Dec. 31, 2025
Regulatory actions for Dec. 31, 2025
Bayosthiti AI to build India-specific RNA sequencing ecosystem
Bayosthiti AI to build India-specific RNA sequencing ecosystem
Judge halts 340B pilot program aimed at duplicate IRA discounts
Judge halts 340B pilot program aimed at duplicate IRA discounts
Financings for Dec. 30, 2025
Financings for Dec. 30, 2025
In the clinic for Dec. 30, 2025
In the clinic for Dec. 30, 2025
Other news to note for Dec. 30, 2025
Other news to note for Dec. 30, 2025
Regulatory actions for Dec. 30, 2025
Regulatory actions for Dec. 30, 2025
Firsts 2025
Firsts 2025
China accepts Hutchmed fanregratinib NDA on single phase II trial
China accepts Hutchmed fanregratinib NDA on single phase II trial
Huayao Jiyuan (Shenzhen) Pharmaceutical discovers new HIF-2α inhibitors
Huayao Jiyuan (Shenzhen) Pharmaceutical discovers new HIF-2α inhibitors
2025 marks a breakthrough year for in vivo gene therapies
2025 marks a breakthrough year for in vivo gene therapies
In 2025, autoimmune work notches scientific, economic successes
In 2025, autoimmune work notches scientific, economic successes
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page